RaySearch Establishes Sales and Support Company in Germany

RaySearch has established a German subsidiary, RaySearch Germany GmbH. The new subsidiary is fully responsible for the marketing, sales and service of RaySearch’s proprietary treatment planning system RayStation® in Germany, Austria and the German-speaking parts of Switzerland. It will serve new as well as existing customers such as DKFZ and WPE in Germany and MedAustron in Austria.

The German subsidiary is led by Mr. Radu Pintea. Mr. Pintea is a trained medical physicist and brings over 20 years' experience from the radiation therapy industry and has held senior sales positions primarily in treatment planning but also in medical equipment and accessories for radiotherapy.

"I am very happy to join RaySearch in this exciting phase. RayStation® is clearly the leading treatment planning system on the market with unique features such as multi-criteria optimization and full support for adaptive therapy and proton therapy. I am off to a flying start and look forward to working with new and existing customers in the region. We will participate as an exhibitor at all the important trade shows in 2014 starting with DEGRO in Düsseldorf," says Radu Pintea, Business Director of RaySearch Germany GmbH.

Johan Löf, CEO of RaySearch, comments: "We have been active in Germany for almost five years since WPE in Essen became the very first RayStation® customer in 2009. Over the years we have supported the German-speaking market from Stockholm. As we now see an increasing demand from the region it is time to increase our presence and I am very happy to welcome Radu Pintea to RaySearch. With his extensive experience he will be instrumental to expand and support our growing customer base in the region."

About RayStation®
RayStation® integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron and proton therapy. The system is built on the latest software architecture and has a graphical user interface offering state-of-the-art usability.

About RaySearch
RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch’s products are mainly sold through license agreements with leading partners such as Philips, Nucletron, IBA, Varian and Brainlab. To date, 15 products have been launched through partners and RaySearch’s software is used at 2,500 clinics in more than 65 countries. In addition, RaySearch offers the proprietary treatment planning system RayStation® directly to clinics. RaySearch was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the company is listed in the Small Cap segment on NASDAQ OMX Stockholm.

Most Popular Now

Do Fitness Apps do More Harm than Good?

A study published in the British Journal of Health Psychology reveals the negative behavioral and psychological consequences of commercial fitness apps reported by users on social media. These impacts may...

AI Tool Beats Humans at Detecting Parasi…

Scientists at ARUP Laboratories have developed an artificial intelligence (AI) tool that detects intestinal parasites in stool samples more quickly and accurately than traditional methods, potentially transforming how labs diagnose...

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...

AI can Better Predict Future Risk for He…

A landmark study led by University' experts has shown that artificial intelligence can better predict how doctors should treat patients following a heart attack. The study, conducted by an international...

A New AI Model Improves the Prediction o…

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the...

AI System Finds Crucial Clues for Diagno…

Doctors often must make critical decisions in minutes, relying on incomplete information. While electronic health records contain vast amounts of patient data, much of it remains difficult to interpret quickly...